As injectable therapies evolve, so do the challenges of delivering them. Credence MedSystems has launched the Industry Education home on our website where we share practical perspectives on important topics in injectable drug delivery, including larger-volume prefilled syringes, precision intravitreal dosing, dual chamber delivery and other emerging drug delivery challenges.
Over the past few years, several major pharmaceutical companies have carved out or spun off their consumer healthcare (CHC) divisions, creating standalone organizations with the scale and scientific heritage of pharma but the commercial ambitions of fast-moving consumer brands. High-profile examples include Kenvue from Johnson & Johnson, Haleon from GSK and Opella from Sanofi, moves intended to unlock greater focus, agility and capital efficiency in businesses that operate under different market dynamics from prescription pharmaceuticals.
In this case study, OSDPredict™ narrowed formulation options early, focusing development on the most viable strategies which reduced experimental burden and conserved valuable materials.
Vardan Ter-Antonyan, Casey Kikendall, and John Davis review the formulation principles governing calcium alginate bead performance and discuss the relationship between bead structure and controlled release.
Dissolution-permeation testing is helping drug developers better predict how food affects oral drug absorption by measuring both drug solubilization and membrane permeation, reducing the risk of misleading results from dissolution data alone.
Self-administered drug-device combination products can bring major benefits to clinical trials, improving patient convenience, dosing consistency, compliance, and real-world insight, but they require careful early planning around usability, safety, regulatory requirements, compatibility, manufacturing, and scale-up.
Thermo Fisher ScientificYour trusted CDMO and CRO partner in drug development
Thermo Fisher Scientific is the world leader in serving science, empowering customers to make the world healthier, cleaner, and safer. We accelerate life sciences research, solve complex analytical challenges, enhance laboratory productivity, improve patient health, and develop life-changing therapies. Our global team delivers innovative technologies and pharmaceutical services through trusted brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
Thermo Fisher Scientific serves the pharmaceutical, biotechnology, and life sciences industries as a contract development and manufacturing organization (CDMO) and clinical services partner. Our end-to-end, integrated capabilities support every stage of drug development—from research and development and regulatory support to supply chain management and commercial manufacturing. Learn More
Poor aqueous solubility is a key barrier for a growing share of new drug candidates, limiting their bioavailability and development potential. Evonik’s AEROPERL® 300 Pharma excipient helps formulators improve the solubility and bioavailability of poorly water-soluble APIs. Join presenter Carolina Mathias, Senior Applied Technical Manager at Evonik Smart Effects, on Thursday, November 26 at 9:00 a.m. CET for first-hand formulation guidance.
DRUG DEVELOPMENT DIRECT RESOURCES
Upcoming eNewsletter Features:
November 11 – Parenteral Contract Manufacturing
November 18 – Controlled Release
November 25 – Bioavailability
December 2 – Inhalation Drug Delivery